The Asia Pacific Gabapentin Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).
Gabapentin still remains one of the most prescribed medicines to treat chronic pain. Although chronic pain frequently develops due to an illness or injury, it is a distinct condition in and of itself and not merely a symptom of other illnesses. As a result, chronic pain has a distinct taxonomy and medical description. Recurrent tension-type headaches are one of the most prevalent symptomatic chronic diseases, affecting 1.9 billion people worldwide and contributing to the growing burden of chronic pain.
Neck and low back pain have continuously been the primary causes of disability, accounting for the majority of years lived with disability, with other chronic pain diseases making significant appearances in the top 10. An episode of shingles can result in postherpetic neuralgia. According to the CDC, approximately 10% to 18% of people with shingles develop postherpetic neuralgia. The FDA has only approved using gabapentin under the trade name Gralise to manage postherpetic neuralgia (PHN). An extended-release medication called Horizant (gabapentin enacarbil) is prescribed to treat adults with PHN and restless legs syndrome.
Chronic pain is one of the most important healthcare concerns in the region as the proportion of the aging population and the frequency of associated illnesses rises. Additionally, notwithstanding the Southeast Asian nations' achievements in sustainable health care and forward-thinking economic growth, controlling epilepsy is still difficult because of the huge cultural, racial, and political variety among its population. This can be considered a management gap, diagnostic accuracy & facilities gaps, medical & surgical treatment gaps, and stigma reduction gaps. The burden of these health issues is increasing the demand for gabapentin drugs significantly. Therefore, in the coming years, the region presents lucrative growth opportunities for the gabapentin market.
The China market dominated the Asia Pacific Gabapentin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $203.6 million by 2028. The Japan market is estimated to grow a CAGR of 4.6% during (2022 - 2028). Additionally, The India market would experience a CAGR of 5.9% during (2022 - 2028).
Based on Application, the market is segmented into Epilepsy, Restless Legs Syndrome, Neuropathic Pain, and Others. Based on Dosage Form, the market is segmented into Capsule, Tablet and Oral Solution. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Gabapentin Market is Projected to reach USD 2.6 Billion by 2028, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Aurobindo Pharma Limited, Amneal Pharmaceuticals, Inc., Cipla Limited, and Apotex, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Epilepsy
- Restless Legs Syndrome
- Neuropathic Pain
- Others
By Dosage Form
- Capsule
- Tablet
- Oral Solution
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Zydus Lifesciences Ltd.
- Glenmark Pharmaceuticals Limited
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Aurobindo Pharma Limited
- Amneal Pharmaceuticals, Inc.
- Cipla Limited
- Apotex, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Gabapentin Market, by Application
1.4.2 Asia Pacific Gabapentin Market, by Dosage Form
1.4.3 Asia Pacific Gabapentin Market, by Distribution Channel
1.4.4 Asia Pacific Gabapentin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Gabapentin Market by Application
3.1 Asia Pacific Epilepsy Market by Country
3.2 Asia Pacific Restless Legs Syndrome Market by Country
3.3 Asia Pacific Neuropathic Pain Market by Country
3.4 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Gabapentin Market by Dosage Form
4.1 Asia Pacific Capsule Market by Country
4.2 Asia Pacific Tablet Market by Country
4.3 Asia Pacific Oral Solution Market by Country
Chapter 5. Asia Pacific Gabapentin Market by Distribution Channel
5.1 Asia Pacific Hospital Pharmacy Market by Country
5.2 Asia Pacific Retail Pharmacy Market by Country
5.3 Asia Pacific Online Pharmacy Market by Country
Chapter 6. Asia Pacific Gabapentin Market by Country
6.1 China Gabapentin Market
6.1.1 China Gabapentin Market by Application
6.1.2 China Gabapentin Market by Dosage Form
6.1.3 China Gabapentin Market by Distribution Channel
6.2 Japan Gabapentin Market
6.2.1 Japan Gabapentin Market by Application
6.2.2 Japan Gabapentin Market by Dosage Form
6.2.3 Japan Gabapentin Market by Distribution Channel
6.3 India Gabapentin Market
6.3.1 India Gabapentin Market by Application
6.3.2 India Gabapentin Market by Dosage Form
6.3.3 India Gabapentin Market by Distribution Channel
6.4 South Korea Gabapentin Market
6.4.1 South Korea Gabapentin Market by Application
6.4.2 South Korea Gabapentin Market by Dosage Form
6.4.3 South Korea Gabapentin Market by Distribution Channel
6.5 Singapore Gabapentin Market
6.5.1 Singapore Gabapentin Market by Application
6.5.2 Singapore Gabapentin Market by Dosage Form
6.5.3 Singapore Gabapentin Market by Distribution Channel
6.6 Malaysia Gabapentin Market
6.6.1 Malaysia Gabapentin Market by Application
6.6.2 Malaysia Gabapentin Market by Dosage Form
6.6.3 Malaysia Gabapentin Market by Distribution Channel
6.7 Rest of Asia Pacific Gabapentin Market
6.7.1 Rest of Asia Pacific Gabapentin Market by Application
6.7.2 Rest of Asia Pacific Gabapentin Market by Dosage Form
6.7.3 Rest of Asia Pacific Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
TABLE 1 Asia Pacific Gabapentin Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Gabapentin Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Capsule Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Capsule Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Tablet Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Tablet Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 31 China Gabapentin Market, 2018 - 2021, USD Million
TABLE 32 China Gabapentin Market, 2022 - 2028, USD Million
TABLE 33 China Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 34 China Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 35 China Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 36 China Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 37 China Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 China Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 Japan Gabapentin Market, 2018 - 2021, USD Million
TABLE 40 Japan Gabapentin Market, 2022 - 2028, USD Million
TABLE 41 Japan Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 42 Japan Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 43 Japan Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 44 Japan Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 45 Japan Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 Japan Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 India Gabapentin Market, 2018 - 2021, USD Million
TABLE 48 India Gabapentin Market, 2022 - 2028, USD Million
TABLE 49 India Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 50 India Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 51 India Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 52 India Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 53 India Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 India Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 South Korea Gabapentin Market, 2018 - 2021, USD Million
TABLE 56 South Korea Gabapentin Market, 2022 - 2028, USD Million
TABLE 57 South Korea Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 58 South Korea Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 59 South Korea Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 60 South Korea Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 61 South Korea Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 62 South Korea Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 63 Singapore Gabapentin Market, 2018 - 2021, USD Million
TABLE 64 Singapore Gabapentin Market, 2022 - 2028, USD Million
TABLE 65 Singapore Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 66 Singapore Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 67 Singapore Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 68 Singapore Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 69 Singapore Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 70 Singapore Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 71 Malaysia Gabapentin Market, 2018 - 2021, USD Million
TABLE 72 Malaysia Gabapentin Market, 2022 - 2028, USD Million
TABLE 73 Malaysia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 74 Malaysia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 75 Malaysia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 76 Malaysia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 77 Malaysia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 Malaysia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Gabapentin Market, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Gabapentin Market, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 87 Key Information – Zydus Lifesciences Ltd.
TABLE 88 Key Information – Glenmark Pharmaceuticals Limited
TABLE 89 Key Information – Pfizer, Inc.
TABLE 90 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 91 Key Information – Alkem Laboratories Ltd.
TABLE 92 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 93 key information – Aurobindo Pharma Limited
TABLE 94 Key Information – Amneal Pharmaceuticals, INc.
TABLE 95 Key Information – Cipla Limited
TABLE 96 Key Information – Apotex, Inc.
List of Figures
FIG 1 Methodology for the research